Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Cardiol ; 63(11): 702-8, 1989 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-2646896

RESUMO

The possibility of discontinuing--compared to reducing--antihypertensive drug treatment was investigated in 606 male hypertensive patients with entry diastolic blood pressure (BP) in the range of 90 to 114 mm Hg. Diastolic BP was controlled at less than 90 mm Hg with 1 of 4 regimens: low dose hydrochlorothiazide (HCTZ), 25 mg twice daily; high dose HCTZ, 50 mg twice daily; or high dose HCTZ plus a low or high dose of a step II drug (propranolol, clonidine or reserpine). After 6 months of treatment that controlled BP, dosages were reduced in two-thirds of the patients. In those patients receiving low dose HCTZ and randomized to dose reduction, antihypertensive drugs were completely discontinued. Although approximately half of these patients remained normotensive for the first 6 months, a significantly greater proportion had elevation of BP compared to the control group, which continued to receive treatment (p less than 0.0001). In the high dose HCTZ drug group, the proportion of patients remaining normotensive did not differ among those stepped down to low dose HCTZ and the fully treated control group. While not achieving significance the trend was similar with the step II regimens. Although some patients remained normotensive after discontinuation of step II drugs, a greater proportion returned to elevated BP than when step II dosage was unchanged. Therefore, while stopping therapy may be effective in some patients, a decreased dosage is significantly more effective as a method for maintaining an antihypertensive effect. Decreasing drug dosages offers the dual benefit of minimizing side effects and reducing drug costs.


Assuntos
Anti-Hipertensivos/administração & dosagem , Hipertensão/tratamento farmacológico , Anti-Hipertensivos/uso terapêutico , Ensaios Clínicos como Assunto , Clonidina/administração & dosagem , Esquema de Medicação , Seguimentos , Humanos , Hidroclorotiazida/administração & dosagem , Masculino , Propranolol/administração & dosagem , Distribuição Aleatória , Reserpina/administração & dosagem , Fatores de Tempo
3.
Angiology ; 33(4): 277-9, 1982 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7073020

RESUMO

Extracardiac sounds secondary to cardiac pacing are well known, but the murmurs originating in the heart after pacemaker insertion are rare. A patient who developed musical systolic murmur following temporary transvenous endocardial pacemaker insertion is described. It is concluded that the murmur was produced by vibrations caused by the pacing catheter and the tricuspid valve or some other intracardiac structure.


Assuntos
Cateterismo/efeitos adversos , Auscultação Cardíaca , Sopros Cardíacos , Contração Miocárdica , Marca-Passo Artificial/efeitos adversos , Sístole , Bloqueio Cardíaco/terapia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...